<DOC>
	<DOC>NCT01326494</DOC>
	<brief_summary>The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.</brief_summary>
	<brief_title>Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia</brief_title>
	<detailed_description>In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation. Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation. The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>2 or more presentations to Emergency department in a 12 month period less then 2 presentations to Emergency department in a 12 month period</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Upper Respiratory Tract Infection</keyword>
	<keyword>Asthma</keyword>
	<keyword>URTI induced exacerbation of Asthma</keyword>
</DOC>